JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4301
Danaos Corp
DAC
$3.01B
| $114K | ﹤0.01% |
28,582
+12,164
| +74% | +$74.3K |
2019 Q4
1 quarter
|
|
4302
Reading International Class A
RDI
$43.7M
| $114K | ﹤0.01% |
29,286
+10,269
| +54% | +$87.3K |
2016 Q4
13 quarters
|
|
4303
Avalo Therapeutics
AVTX
$781M
| $113K | ﹤0.01% |
16
-3
| -16% | -$31.7K |
2019 Q1
4 quarters
|
|
|
AXLA
4304
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $113K | ﹤0.01% |
1,322
+69
| +6% | +$7.07K |
2019 Q2
3 quarters
|
|
4305
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.83B
| $112K | ﹤0.01% |
2,420
| – | – |
2018 Q1
8 quarters
|
|
4306
Forum Energy Technologies
FET
$1.02B
| $111K | ﹤0.01% |
31,324
-1,507
| -5% | -$27.9K |
2016 Q4
13 quarters
|
|
4307
Kimbell Royalty Partners
KRP
$1.5B
| $111K | ﹤0.01% |
19,000
-4,470
| -19% | -$53.8K |
2019 Q1
4 quarters
|
|
4308
Universal Technical Institute
UTI
$1.05B
| $111K | ﹤0.01% |
+18,718
| New | +$133K |
2020 Q1
0 quarters
|
|
4309
Team
TISI
$132M
| $110K | ﹤0.01% |
1,684
+27
| +2% | +$3.35K |
2013 Q2
27 quarters
|
|
|
PGNX
4310
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $110K | ﹤0.01% |
29,048
-8,369
| -22% | -$36.1K |
2017 Q4
9 quarters
|
|
4311
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $109K | ﹤0.01% |
5,022
-1,464
| -23% | -$40.5K |
2019 Q4
1 quarter
|
|
|
NE
4312
DELISTED
Noble Corporation
NE
| $109K | ﹤0.01% |
415,641
+334,293
| +411% | +$249K |
2013 Q2
27 quarters
|
|
4313
Aprea Therapeutics
APRE
$8.38M
| $108K | ﹤0.01% |
155
+50
| +48% | +$36.7K |
2019 Q4
1 quarter
|
|
4314
Siebert Financial
SIEB
$92.5M
| $108K | ﹤0.01% |
14,834
+4,839
| +48% | +$38.8K |
2018 Q2
7 quarters
|
|
4315
Alkermes
ALKS
$7.11B
| $107K | ﹤0.01% |
+7,438
| New | +$133K |
2020 Q1
0 quarters
|
|
4316
BGSF Inc
BGSF
$54.3M
| $107K | ﹤0.01% |
14,293
+9,054
| +173% | +$152K |
2016 Q4
13 quarters
|
|
4317
Invesco S&P MidCap Low Volatility ETF
XMLV
$693M
| $107K | ﹤0.01% |
2,696
| – | – |
2018 Q1
8 quarters
|
|
|
BZUN
4318
Baozun
BZUN
$185M
| $106K | ﹤0.01% |
3,795
-836
| -18% | -$26.3K |
2019 Q4
1 quarter
|
|
4319
Citizens
CIA
$180M
| $106K | ﹤0.01% |
16,234
+15
| +0.1% | +$93 |
2017 Q4
9 quarters
|
|
4320
Magnite
MGNI
$3.61B
| $106K | ﹤0.01% |
19,146
-240,673
| -93% | -$2.21M |
2014 Q2
23 quarters
|
|
|
MIK
4321
DELISTED
Michaels Stores, Inc
MIK
| $106K | ﹤0.01% |
64,934
-87
| -0.1% | -$412 |
2015 Q1
20 quarters
|
|
4322
United States Brent Oil Fund
BNO
$778M
| $105K | ﹤0.01% |
13,263
+12,163
| +1,106% | +$197K |
2018 Q4
5 quarters
|
|
4323
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.07B
| $105K | ﹤0.01% |
1,498
+431
| +40% | +$33.9K |
2015 Q4
17 quarters
|
|
4324
Exicure
XCUR
$7.79M
| $104K | ﹤0.01% |
471
-1,048
| -69% | -$331K |
2019 Q4
1 quarter
|
|
|
BDSI
4325
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $104K | ﹤0.01% |
27,408
+25
| +0.1% | +$123 |
2018 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.